Compare Ginkgo Bioworks Holdings Inc (DNA) vs J B Hunt Transport Services Inc (JBHT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs J B Hunt Transport Services Inc — how do they compare? Ginkgo Bioworks Holdings Inc trades at $13 (market cap $763.64M), while J B Hunt Transport Services Inc trades at $229.26 (market cap $21.45B). The key difference: J B Hunt Transport Services Inc is far larger — about 28.1× Ginkgo Bioworks Holdings Inc's market cap, and J B Hunt Transport Services Inc pays a 0.79% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Ginkgo Bioworks Holdings Inc for 7 Days and J B Hunt Transport Services Inc for 46 Days on average.
| DNA | JBHT | |
|---|---|---|
Market Cap | $763.64M | $21.45B |
Volume | 3,204,177 | 1,028,680 |
Sector | Health | Industrials |
52-Week High | $15.83 | $298.41 |
52-Week Low | $5.48 | $137.09 |
Typical Hold Time | 7 Days | 46 Days |
Enterprise Value | $865.59M | $22.59B |
Dividend Yield | — | 0.79% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Ginkgo Bioworks (DNA) trades at $11.34, down 1.13% on the day, with a bullish technical signal from moving averages. The company reported a net loss of $312.76 million on $170.16 million revenue for 2025, with negative cash flow. Recent news includes a $17.5 million ARPA-H subcontract for RNA medicine manufacturing, highlighting ongoing strategic initiatives despite financial challenges.
The outlook remains speculative given persistent losses and cash burn, though analyst consensus is divided. Key risks include execution on revenue growth and path to profitability. Upside depends on successful commercialization of its biotech platform and partnerships, but high volatility and fundamental weakness warrant caution for investors.
JBHT trades at $228.42, up 2.6% with strong earnings beats in recent quarters. Technical indicators show bearish momentum with support at $225 and resistance at $230. The company maintains solid fundamentals with $12B revenue, 5.31% net margin, and 18.45% ROE, though valuation metrics appear elevated with P/E of 32.5. Recent news highlights ongoing securities investigations and Q3 earnings anticipation.
Outlook remains cautiously optimistic with analyst consensus price target of $289.40 (27% upside) and 59% buy ratings. Key risks include legal investigations, cost pressures from diesel prices, and competitive trucking industry. Earnings growth and freight demand provide catalysts, but legal overhang warrants monitoring.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About J B Hunt Transport Services Inc
J.B. Hunt Transport Services ranks among the top surface transportation companies in North America by revenue. Its primary operating segments are intermodal delivery, which uses the Class I rail carriers for the underlying line-haul movement of its owned containers (45% of sales in 2021).
Read more on JBHT →
